JIN GAMS: Open Payments
NPI 1497258180 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 13 payments from 8 companies in 2025. Trend: 2023 $230 · 2024 $217 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 3 | $74 |
| Melinta Therapeutics, LLC | 3 | $61 |
| Paratek Pharmaceuticals, Inc. | 2 | $35 |
| Gilead Sciences, Inc. | 1 | $30 |
| Astellas Pharma US Inc | 1 | $28 |
| Insmed, Inc. | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: Rezzayo, DOVATO, NUZYRA, Biktarvy, Cresemba, CABENUVA, Arikayce, VOWST.
Industry payments across SC — which companies pay providers there.
